CBER Reports
CBER Reports older than 2 years are available on FDA Archive.
General
- FDA Report to Congress: Least Burdensome Training Audit
- FDA Report to Congress: Least Burdensome Training Audit Addendum
- FY 2020 Report from the Director
- FY 2019 Report from the Director
- FY 2018 Report from the Director
- FY 2017 Report from the Director
- User Fee Billable Biologic Products and Potencies Approved Under Section 351 of PHS Act
- Biologics PREA Reviews and Labeling Changes
- PREA Non-Compliance Letters